Momelotinib3.
3 Inquiries
1056634-68-4
Hefei
5G/bag
2025-03-17
13-Dimethyladamantane,1-Bromo-35-dimethyladamantane,perhydroacenaphthylene,4-[1,1-bis(4-hydroxyphenyl)ethyl]phenol,CYCLOBUTANE-1,2-DICARBOXYLIC ACID DIMETHYL ESTER, TRANS
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Momelotinib
Other Name:Benzamide,N-(cyanomethyl)-4-[2-[[4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]-;N-(Cyanomethyl)-4-[2-[[4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]benzamide;CYT 387;Momelotinib;CYT 11387;CYT-0387;GS 0387;N-(Cyanomethyl)-4-[2-(4-morpholinoanilino)pyrimidin-4-yl]benzamide;CYT 387 mesylate;1160597-06-7
CAS No.:1056634-68-4
Molecular Formula:C23H22N6O2
InChIKeys:InChIKey=ZVHNDZWQTBEVRY-UHFFFAOYSA-N
Molecular Weight:414.45978
Exact Mass:414.46
UNII:6O01GMS00P
NCI Thesaurus Code:C88311
HScode:2934999090
Categories:
Characteristics-
PSA:
103
XLogP3:2.6
Appearance:Solid
Density:1.292
Refractive Index:1.646
Storage Conditions:at -20ºC 2 years
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
13-Dimethyladamantane,1-Bromo-35-dimethyladamantane,perhydroacenaphthylene,4-[1,1-bis(4-hydroxyphenyl)ethyl]phenol,CYCLOBUTANE-1,2-DICARBOXYLIC ACID DIMETHYL ESTER, TRANS
-
Location:
Room 1623,Building A, ZhongqiaoCenter,Goverment District,Hefei city,Anhui Province,China
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2019
-
-
Inquiry History3 Inquiries
Country Product Purchase Quantity Date Posted 
Pakistan
Momelotinib
1 KG May 13, 2025
Pakistan
Momelotinib
1 KG May 12, 2025 
United States
CYT387/1056634-68-4/with high purity 99%
5 G Feb 15, 2025 Post an enquiry for this product